Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RNA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RNA
Atrium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RNA
Atrium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
RNA
Uncorrelated: r 0.21 · 155D.
Shared co-movers
2
with LLY
with RNA
MRK
Merck & Co., Inc.
r 0.42
r 0.32
ABBV
AbbVie Inc.
r 0.37
r 0.28
LLY, solid
RNA, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,419.27
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RNA
Atrium Therapeutics, Inc.
Change
8.64
▼
−0.87%
· post 8.64
Closed
Nov 4 '26
Mkt cap
$148.5M
Revenue
$3M
Q2 FY26
Revenue
—
vs
Compare
Closed
Nov 4 '26
LLY
ELI Lilly & Co
vs
RNA
Atrium Therapeutics, Inc.
1,417.89
▲
+0.60%
post 1,419.27
Price
8.64
▼
−0.87%
post 8.64
$1.3T
Mkt cap
$148.5M
Q3 FY26
$24.4B
Revenue
$3M
Q2 FY26
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,417.89
▲
+0.60%
vs
RNA
8.64
▼
−0.87%
Closed
Nov 4 '26